CSat Investment Advisory’s DexCom DXCM Stock Holding History

CSat Investment Advisory’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$24K	Buy	268 +68	+34%	+$6.38K	0.02%	344
2020 Q4	$18K	Sell	200 -2,832	-93%	-$253K	0.02%	351
2020 Q3	$312K	Buy	3,032 +220	+8%	+$23K	0.03%	215
2020 Q2	$285K	Buy	2,812 +1,496	+114%	+$134K	0.03%	249
2020 Q1	$89K	Buy	1,316 +224	+21%	+$13.9K	0.02%	367
2019 Q4	$60K	Buy	1,092 +136	+14%	+$6.45K	0.02%	560
2019 Q3	$36K	Buy	956 +136	+17%	+$5.28K	0.01%	627
2019 Q2	$31K	Buy	+820	New	+$25.8K	0.01%	642

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

CSat Investment Advisory's DXCM Position: Q1 2021 in Review

CSat Investment Advisory increased its DexCom (DXCM) stake by 34% in Q1 2021, buying an estimated $6.38K and bringing the position to 268 shares worth $24K. The position accounts for 0.02% of the portfolio, ranked #344.

CSat Investment Advisory first reported a position in DXCM in Q2 2019 and has held it in 8 quarters since. The position peaked at $312K in Q3 2020. 730 funds tracked by Wall St. Rank hold DXCM as of Q1 2021.

CSat Investment Advisory held 268 shares of DexCom worth $24K as of Q1 2021.
CSat Investment Advisory bought 68 DexCom shares in Q1 2021, an estimated $6.38K.
DexCom made up 0.02% of CSat Investment Advisory's portfolio in Q1 2021, its #344 holding.
CSat Investment Advisory first reported a position in DexCom in Q2 2019 and has held it in 8 quarters since.
CSat Investment Advisory's DexCom position peaked at $312K in Q3 2020.
730 funds tracked by Wall St. Rank held DexCom as of Q1 2021.

Based on CSat Investment Advisory's 13F filing for Q1 2021, filed 13 May 2021.